Blog
RSS FeedPosted by Michael Wonder on 19 Nov 2019
Lung cancer and leukaemia treatments to be added to PBS
19 November 2019 - “Game changing” drugs for types of lung cancer and leukaemia will be added to the Pharmaceutical Benefits ...
Posted by Michael Wonder on 12 Nov 2019
Rare Disease Fund now covers Pompe disease, a rare inherited neuromuscular disorder
3 November 2019 - The Rare Disease Fund now covers Singaporeans with Pompe disease - a rare inherited neuromuscular disorder ...
Posted by Michael Wonder on 12 Nov 2019
It’s tiny biotechs — not big drug makers — that fear ‘nuclear winter’ from Pelosi’s drug pricing bill
12 November 2019 - No one asked Paul Hastings what he thinks about Speaker Nancy Pelosi’s major new drug pricing ...
Posted by Michael Wonder on 12 Nov 2019
Google’s ‘Project Nightingale’ gathers personal health data on millions of Americans
11 November 2019 - Search giant is amassing health records from Ascension facilities in 21 states; patients not yet informed. ...
Posted by Michael Wonder on 12 Nov 2019
Merck’s Ervebo [Ebola Zaire vaccine (rVSVΔG-ZEBOV-GP) live] granted conditional approval in the European Union
12 November 2019 - Authorisation represents significant advancement in the global response to Ebola. ...
Posted by Michael Wonder on 12 Nov 2019
Lung cancer ALK+NSCLC genetic mutation screening could save lives - doctors
12 November 2019 - Lives are being needlessly cut short because there's no universal testing for a type of lung ...
Posted by Michael Wonder on 12 Nov 2019
Three deaths following epilepsy drug brand switch
12 November 2019 - Three deaths have been reported to the Centre for Adverse Reactions Monitoring after PHARMAC forced patients ...
Posted by Michael Wonder on 11 Nov 2019
Breast and kidney cancer drugs get approval for use across Scotland's NHS
11 November 2019 - Medicines for breast and kidney cancers are among five new drugs which can now be used ...
Posted by Michael Wonder on 11 Nov 2019
FDA admits it goofed when granting orphan status to an opioid addiction treatment
8 November 2019 - In an unusual move, the FDA has acknowledged a mistake and revoked orphan drug status for ...
Posted by Michael Wonder on 11 Nov 2019
U.S. FDA accepts for priority review Bristol-Myers Squibb’s application for Opdivo (nivolumab) plus Yervoy (ipilimumab) combination for patients with previously treated advanced hepatocellular carcinoma
11 November 2019 - The FDA also granted Opdivo plus Yervoy Breakthrough Therapy Designation for this potential indication. ...
Posted by Michael Wonder on 11 Nov 2019
F2G receives US FDA breakthrough therapy designation for Olorofim
11 November 2019 - First anti-fungal agent to receive breakthrough therapy designation. ...
Posted by Michael Wonder on 11 Nov 2019
Lipocine receives complete response letter for Tlando from U.S. FDA
11 November 2019 - Lipocine announced today that it has received a complete response letter from the United States Food ...
Posted by Michael Wonder on 11 Nov 2019
Medical cannabis ruled out for chronic pain by NHS drug watchdog in decision branded 'devastating'
11 November 2019 - Cannabis should not be prescribed for chronic pain, the NHS funding watchdog has ruled, in a ...
Posted by Michael Wonder on 11 Nov 2019
More than ever, Democratic presidential hopefuls want to take on pharma. Here’s how they’d do it.
11 November 2019 - President Trump has made drug pricing a key policy tenet of his three-year tenure in the ...
Posted by Michael Wonder on 11 Nov 2019
China’s drug market is opening up
11 November 2019 - Beijing’s health-care reforms are giving global pharmaceutical companies better access to the world’s second-largest drug market. ...
Posted by Michael Wonder on 11 Nov 2019
SMC - November 2019 decisions
11 November 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...